Skip to main content
PYXS
NASDAQ Life Sciences

Pyxis Extends Cash Runway to H1 2028, Sets Mid-2027 Phase 3 Start

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$1.65
Mkt Cap
$198.509M
52W Low
$1.03
52W High
$5.55
52W Position info
60% above low
Off High info
70% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

PYXS sits 60% above its 52-week low of $1.03.

Summary

Pyxis now says quarter-end cash plus net proceeds from its October public offering will fund operations into the first half of 2028, roughly a year beyond the Q2 2027 runway it guided in August. That October raise brought in $102.8 million net, which is what buys the extra time. The company also laid out a global Phase 3 trial start for mid-2027, with FDA dose-selection feedback expected in Q1 2027 as the gate before it. Safety looks clean so far, with no new signals across 35 evaluable patients. The runway removes near-term financing pressure, but the release gives no cash balance or prior-period comparison, so the size of the cushion is unclear. Q1 2027 FDA feedback is the next hard checkpoint for the Phase 3 plan. For the third quarter, Pyxis posted a loss of 24 cents a share and net income of USD -19.984 million.

At the time of this announcement, PYXS was trading at $1.65 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $198.5M. The 52-week trading range was $1.03 to $5.55. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

PYXS - Latest Insights

PYXS
Nov 19, 2026, 7:01 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.50
Real-time Price: $1.80 info
Change: +$0.300 (+20%) info
Market Cap: $215.294M info
PYXS
Nov 18, 2026, 6:01 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $1.46
Real-time Price: $1.80 info
Change: +$0.340 (+23%) info
Market Cap: $215.294M info
PYXS
Nov 13, 2026, 4:17 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.58
Real-time Price: $1.80 info
Change: +$0.220 (+14%) info
Market Cap: $215.294M info
PYXS
Nov 05, 2026, 7:45 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.65
Real-time Price: $1.80 info
Change: +$0.150 (+9%) info
Market Cap: $215.294M info
PYXS
Nov 05, 2026, 7:39 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.65
Real-time Price: $1.80 info
Change: +$0.150 (+9%) info
Market Cap: $215.294M info